A gene linked to longer survival in one type of childhood brain tumor
Original title: PSEN1 Expression Identifies a Developmentally Distinct Favorable-Prognosis State in SHH α Medulloblastoma
How far along is this research?
This is a preprint. Other scientists have not checked it yet, so treat it as an early signal rather than an answer.
This only looked back at old data from past patients. Nothing new was tested in people.
The short version
Kids whose tumors made more of a gene called PSEN1 lived longer, but only in one tumor group.
What was studied. Researchers looked at stored gene data from past medulloblastoma tumors. Medulloblastoma is the most common brain cancer in kids. They checked a gene called PSEN1 and how long patients lived.
What they found. High PSEN1 levels went along with longer survival. This held true only in the tumor group called SHH. The same pattern showed up again in a second, separate set of patients. PSEN1 was also active in the growing human cerebellum and in other childhood brain tumors.
What this means, and what it doesn't
What it could mean: PSEN1 might mark a milder form of SHH medulloblastoma. That could one day help doctors guess how a child will do. For now it is only an idea to test further.
What it doesn't mean: This does not mean there is a new treatment. No one was given a drug in this study. No new test is ready for the clinic. This is early work using old data. It is a long way from everyday care. It is not a cure or a promise of one.
Source: bioRxiv (preprint), August 24, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.